(Formerly known as Central Clinical School)
 |
| L-R: Drs Zhoujie Ding, Matt Hudson and Robb Wesselingh |
Matt, Zhoujie and Rob were awarded funding in the fourth and final round for 2022 of the GIN Hub's Pitch for their project, "Developing the first Australian mouse model of anti-NMDAR autoimmune encephalitis". We look forward to seeing the results of this collaboration between the Neuroscience and Immunology and Pathology departments.
 |
| L-R: Muhammad Javaid, Robb Wesselingh and Xianglong Xu |
Muhammad Javaid completed his PhD on 2 August, "Drug-resistant focal cortical dysplasia in epilepsy: insights from cellular models of neuronal development". He was supervised by Professor Patrick Kwan and Dr Ana Antonic-Baker (Department of Neuroscience).
 | ||
|
Researchers from the Neuroimmunology, Neurology, Neuroinflammation Laboratory led by Dr Mastura Monif in the Department of Neuroscience have identified electroclinical biomarkers that differentiate one particular type of autoimmune encephalitis (AE), known as N-methyl D-aspartate receptor (NMDAR) antibody-associated encephalitis (anti-NMDAR) from other subtypes of AE.
AE is a brain inflammation disorder caused by antibodies. A person’s immune system mistakenly targets different proteins in their brain causing damage and inflammation. This can result in different neurological symptoms including seizures and memory problems. AE can be classified into different subtypes based on the brain protein targeted by the antibodies produced.
 |
| Register here for the 9 Dec forum, 7-8 pm |
What happens next with COVID-19? It's complicated... Once infected with COVID-19, the illness can cause devastating complications which we don't yet understand. Register here for our 9 Dec forum
A forum, "COVID-19: What could happen next?" on 9 Dec at 7-8 pm will give you the chance to hear from our panel of diabetes and neurology experts on the urgent need to know the extent and causes of new-onset and dysfunction with diabetes and neurological conditions. They'll outline how registries are vital to provide the best interventions and management for treatment, and to understand the potential longer-term impact on the health of people who have been infected.
